ResearcherUniversity of Chieti-PescaraNo recent work listed
Nicola Tinari
Matched on ORCID iD 0000-0001-8449-5407; OpenAlex author ID A5029630690. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper
Papers 7
- High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results f… Co-author DOI 10.3390/cancers14194748↗
- Exosomes as Pleiotropic Players in Pancreatic Cancer. Co-author DOI 10.3390/biomedicines9030275↗
- Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. Co-author DOI 10.3390/cancers13163946↗
- The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective. Co-author DOI 10.3390/cancers12071849↗
- The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer. Co-author DOI 10.3390/cancers11122042↗
- Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells. Co-author DOI 10.1186/s13046-018-0904-2↗
- An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitors. Co-author DOI 10.2174/156800912800190884↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rosalba Florio · 6 shared papers, 2018–2022 · strength 0.66
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946↗
- Paper Exosomes as Pleiotropic Players in Pancreatic Cancer. DOI 10.3390/biomedicines9030275↗
- Paper The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective. DOI 10.3390/cancers12071849↗
- Laura De Lellis · 6 shared papers, 2018–2022 · strength 0.66
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946↗
- Paper Exosomes as Pleiotropic Players in Pancreatic Cancer. DOI 10.3390/biomedicines9030275↗
- Paper The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective. DOI 10.3390/cancers12071849↗
- Alessandro Cama · 6 shared papers, 2018–2022 · strength 0.66
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946↗
- Paper Exosomes as Pleiotropic Players in Pancreatic Cancer. DOI 10.3390/biomedicines9030275↗
- Paper The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective. DOI 10.3390/cancers12071849↗
- Serena Veschi · 6 shared papers, 2018–2022 · strength 0.66
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946↗
- Paper Exosomes as Pleiotropic Players in Pancreatic Cancer. DOI 10.3390/biomedicines9030275↗
- Paper The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective. DOI 10.3390/cancers12071849↗
- Davide Brocco · 4 shared papers, 2020–2022 · strength 0.50
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946↗
- Paper Exosomes as Pleiotropic Players in Pancreatic Cancer. DOI 10.3390/biomedicines9030275↗
- Paper The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective. DOI 10.3390/cancers12071849↗
- Pierluigi Di Sebastiano · 2 shared papers, 2018–2022 · strength 0.19
- Paper High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Pa… DOI 10.3390/cancers14194748↗
- Paper Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in p… DOI 10.1186/s13046-018-0904-2↗
- Paola Lanuti · 2 shared papers, 2018–2022 · strength 0.19
- Paper High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Pa… DOI 10.3390/cancers14194748↗
- Paper Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in p… DOI 10.1186/s13046-018-0904-2↗
- Zhirajr Mokini · 1 shared paper, 2021 · strength 0.13
- Fabio F. di Mola · 1 shared paper, 2022 · strength 0.11
- Clara Natoli · 2 shared papers, 2012–2018 · strength 0.11
- Paper Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in p… DOI 10.1186/s13046-018-0904-2↗
- Paper An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitors. DOI 10.2174/156800912800190884↗
- Rosa Amoroso · 1 shared paper, 2019 · strength 0.08
- Stefano Iacobelli · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.